Navegar por autor "Palomera, L."
Mostrando ítems 1-2 de 2
-
Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial
2019- Penalver, F. J.; Marquez, J. A.; Duran, S.; Giraldo, P.; Martin, A.; [et al.]